89 related articles for article (PubMed ID: 7578406)
1. Expression of biologically active human factor IX in human hematopoietic cells after retroviral vector-mediated gene transduction.
Hao QL; Malik P; Salazar R; Tang H; Gordon EM; Kohn DB
Hum Gene Ther; 1995 Jul; 6(7):873-80. PubMed ID: 7578406
[TBL] [Abstract][Full Text] [Related]
2. Construction and high expression of retroviral vector with human clotting factor IX cDNA in vitro.
Lu D; Qiu X; Zheng B; Qiu X; Xue J
Sci China B; 1995 Jun; 38(6):705-12. PubMed ID: 7626200
[TBL] [Abstract][Full Text] [Related]
3. Retroviral-mediated gene expression in human myelomonocytic cells: a comparison of hematopoietic cell promoters to viral promoters.
Malik P; Krall WJ; Yu XJ; Zhou C; Kohn DB
Blood; 1995 Oct; 86(8):2993-3005. PubMed ID: 7579392
[TBL] [Abstract][Full Text] [Related]
4. Comparison of retroviral and adeno-associated viral vectors designed to express human clotting factor IX.
Chen L; Perlick H; Morgan RA
Hum Gene Ther; 1997 Jan; 8(2):125-35. PubMed ID: 9017417
[TBL] [Abstract][Full Text] [Related]
5. Primary myoblast-mediated gene transfer: persistent expression of human factor IX in mice.
Yao SN; Smith KJ; Kurachi K
Gene Ther; 1994 Mar; 1(2):99-107. PubMed ID: 7584074
[TBL] [Abstract][Full Text] [Related]
6. High efficient transfer and expression of human clotting factor IX cDNA in cultured human primary skin fibroblasts from hemophilia B patient by retroviral vectors.
Dai YF; Qiu XF; Xue JL; Liu ZD
Sci China B; 1992 Feb; 35(2):183-93. PubMed ID: 1581003
[TBL] [Abstract][Full Text] [Related]
7. Hybrid retroviral vector with MCK enhancers inserted in LTR for stable and specific expression of human factor IX in skeletal muscle.
Wang JM; Hou J; Qiu XF; Kurachi K; Xue JL
Chin Med J (Engl); 2004 Jun; 117(6):893-8. PubMed ID: 15198894
[TBL] [Abstract][Full Text] [Related]
8. Construction of human factor IX expression vectors in retroviral vector frames optimized for muscle cells.
Wang JM; Zheng H; Sugahara Y; Tan J; Yao SN; Olson E; Kurachi K
Hum Gene Ther; 1996 Sep; 7(14):1743-56. PubMed ID: 8886845
[TBL] [Abstract][Full Text] [Related]
9. Expression of coagulation factor IX (Christmas factor) in human hepatoma (HepG2) cell cultures after retroviral vector-mediated transfer.
Gordon EM; Tang H; Salazar RL; Kohn DB
Am J Pediatr Hematol Oncol; 1993 May; 15(2):196-203. PubMed ID: 8388667
[TBL] [Abstract][Full Text] [Related]
10. Production of minigene-containing retroviral vectors using an alphavirus/retrovirus hybrid vector system.
Wahlfors JJ; Morgan RA
Hum Gene Ther; 1999 May; 10(7):1197-206. PubMed ID: 10340551
[TBL] [Abstract][Full Text] [Related]
11. Expression of human factor IX cDNA in mice by implants of genetically modified skin fibroblasts from a hemophilia B patient.
Zhou JM; Dai YF; Qiu XF; Hou GY; Akira Y; Xue JL
Sci China B; 1993 Sep; 36(9):1082-92. PubMed ID: 8274202
[TBL] [Abstract][Full Text] [Related]
12. Long-term expression of human clotting factor IX from retrovirally transduced primary human keratinocytes in vivo.
White SJ; Page SM; Margaritis P; Brownlee GG
Hum Gene Ther; 1998 May; 9(8):1187-95. PubMed ID: 9625258
[TBL] [Abstract][Full Text] [Related]
13. High-level expression from a cytomegalovirus promoter in macrophage cells.
Ramesh N; Shin YK; Lau S; Osborne WR
Hum Gene Ther; 1995 Oct; 6(10):1323-7. PubMed ID: 8590737
[TBL] [Abstract][Full Text] [Related]
14. Toward gene therapy for Gaucher disease.
Kohn DB; Nolta JA; Weinthal J; Bahner I; Yu XJ; Lilley J; Crooks GM
Hum Gene Ther; 1991; 2(2):101-5. PubMed ID: 1911928
[TBL] [Abstract][Full Text] [Related]
15. Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoter.
Hagstrom JN; Couto LB; Scallan C; Burton M; McCleland ML; Fields PA; Arruda VR; Herzog RW; High KA
Blood; 2000 Apr; 95(8):2536-42. PubMed ID: 10753832
[TBL] [Abstract][Full Text] [Related]
16. Differentiation-specific enhancer activity in transduced keratinocytes: a model for epidermal gene therapy.
Page SM; Brownlee GG
Gene Ther; 1998 Mar; 5(3):394-402. PubMed ID: 9614560
[TBL] [Abstract][Full Text] [Related]
17. Transduction of human hematopoietic cells and cell lines using a retroviral vector containing a modified murine CD4 reporter gene.
Bauer TR; Hickstein DD
Hum Gene Ther; 1997 Feb; 8(3):243-52. PubMed ID: 9048191
[TBL] [Abstract][Full Text] [Related]
18. Stage I clinical trial of gene therapy for hemophilia B.
Lu DR; Zhou JM; Zheng B; Qiu XF; Xue JL; Wang JM; Meng PL; Han FL; Ming BH; Wang XP
Sci China B; 1993 Nov; 36(11):1342-51. PubMed ID: 8142023
[TBL] [Abstract][Full Text] [Related]
19. Expression from leukocyte integrin promoters in retroviral vectors.
Bauer TR; Osborne WR; Kwok WW; Hickstein DD
Hum Gene Ther; 1994 Jun; 5(6):709-16. PubMed ID: 7948133
[TBL] [Abstract][Full Text] [Related]
20. Expression of human glucocerebrosidase in murine macrophages: identification of efficient retroviral vectors.
Freas-Lutz DL; Correll PH; Dougherty SF; Xu L; Pluznik DH; Karlsson S
Exp Hematol; 1994 Aug; 22(9):857-65. PubMed ID: 8062885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
